Premium
Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia
Author(s) -
Yu Wentao,
Gao Wei,
Rong Dan,
Wu Zhixian,
Khalil Raouf A.
Publication year - 2019
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/micc.12508
Subject(s) - endocrinology , medicine , endothelial dysfunction , preeclampsia , angiotensin ii , vascular smooth muscle , vascular endothelial growth factor , proinflammatory cytokine , biology , inflammation , blood pressure , pregnancy , smooth muscle , vegf receptors , genetics
Preeclampsia is a pregnancy‐related disorder characterized by hypertension and often fetal intrauterine growth restriction, but the underlying mechanisms are unclear. Defective placentation and apoptosis of invasive cytotrophoblasts cause inadequate remodeling of spiral arteries, placental ischemia, and reduced uterine perfusion pressure ( RUPP ). RUPP causes imbalance between the anti‐angiogenic factors soluble fms‐like tyrosine kinase‐1 and soluble endoglin and the pro‐angiogenic vascular endothelial growth factor and placental growth factor, and stimulates the release of proinflammatory cytokines, hypoxia‐inducible factor, reactive oxygen species, and angiotensin AT 1 receptor agonistic autoantibodies. These circulating factors target the vascular endothelium, smooth muscle and various components of the extracellular matrix. Generalized endotheliosis in systemic, renal, cerebral, and hepatic vessels causes decreases in endothelium‐derived vasodilators such as nitric oxide, prostacyclin and hyperpolarization factor, and increases in vasoconstrictors such as endothelin‐1 and thromboxane A2. Enhanced mechanisms of vascular smooth muscle contraction, such as intracellular Ca 2+ , protein kinase C, and Rho‐kinase cause further increases in vasoconstriction. Changes in matrix metalloproteinases and extracellular matrix cause inadequate vascular remodeling and increased arterial stiffening, leading to further increases in vascular resistance and hypertension. Therapeutic options are currently limited, but understanding the molecular determinants of microvascular dysfunction could help in the design of new approaches for the prediction and management of preeclampsia.